Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-01-20

FDA Approved: ONDANSETRON — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

FDA approved a supplemental application for ondansetron hydrochloride from NorthStar Rx LLC, confirming continued approval of this generic antiemetic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)